[The position of a vasopressin derivative ("DDAVP") in the treatment of haemophilia A (author's transl)].
D001127:Arginine Vasopressin / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003894:Deamino Arginine Vasopressin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D005169:Factor VIII / Q000032:analysis / Q000378:metabolism; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D007700:Kinetics; D008297:Male
D001127:Arginine Vasopressin; D005169:Factor VIII; D003894:Deamino Arginine Vasopressin
Die derzeitige Stellung des Vasopressinanalogs "DDAVP" in der Behandlung der Hämophilie A.